CA
TMO icon

Crewe Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Crewe Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Buy
926
+68
+8% +$32.6K 0.03% 151
2026
Q1 		$422K Buy
858
+2
+0.2% +$1.08K 0.04% 142
2025
Q4 		$496K Hold
856
– – 0.04% 128
2025
Q3 		$415K Buy
+856
New +$398K 0.04% 140
2024
Q3 		– Sell
-1,597
Closed -$883K – 974
2024
Q2 		$883K Sell
1,597
-18
-1% -$10.3K 0.1% 74
2024
Q1 		$939K Buy
+1,615
New +$906K 0.11% 72
2023
Q3 		– Sell
-1,419
Closed -$740K – 882
2023
Q2 		$740K Buy
1,419
+247
+21% +$133K 0.1% 63
2023
Q1 		$676K Sell
1,172
-39
-3% -$22K 0.1% 68
2022
Q4 		$667K Sell
1,211
-88
-7% -$46.6K 0.11% 67
2022
Q3 		$659K Buy
1,299
+290
+29% +$162K 0.12% 61
2022
Q2 		$548K Buy
1,009
+402
+66% +$221K 0.12% 54
2022
Q1 		$358K Buy
607
+255
+72% +$146K 0.07% 70
2021
Q4 		$235K Buy
352
+1
+0.3% +$624 0.05% 76
2021
Q3 		$201K Sell
351
-8
-2% -$4.39K 0.05% 68
2021
Q2 		$181K Sell
359
-11
-3% -$5.19K 0.04% 76
2021
Q1 		$169K Buy
370
+7
+2% +$3.34K 0.04% 72
2020
Q4 		$169K Buy
363
+43
+13% +$20.2K 0.07% 69
2020
Q3 		$141K Buy
320
+83
+35% +$34.3K 0.07% 63
2020
Q2 		$86K Buy
237
+19
+9% +$6.37K 0.04% 83
2020
Q1 		$62K Hold
218
– – 0.04% 78
2019
Q4 		$71K Sell
218
-431
-66% -$131K 0.03% 94
2019
Q3 		$189K Sell
649
-850
-57% -$243K 0.09% 59
2019
Q2 		$440K Buy
1,499
+892
+147% +$246K 0.14% 42
2019
Q1 		$166K Buy
607
+387
+176% +$96.3K 0.05% 64
2018
Q4 		$49K Hold
220
– – 0.02% 111
2018
Q3 		$54K Sell
220
-80
-27% -$18.4K 0.05% 115
2018
Q2 		$62K Buy
300
+149
+99% +$31.6K 0.06% 104
2018
Q1 		$31K Hold
151
– – 0.03% 153
2017
Q4 		$29K Buy
+151
New +$28.9K 0.03% 165

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Crewe Advisors's TMO Position: Q2 2026 in Review

Crewe Advisors increased its Thermo Fisher Scientific (TMO) stake by 7.9% in Q2 2026, buying an estimated $32.6K and bringing the position to 926 shares worth $464K. The position accounts for 0.03% of the portfolio, ranked #151.

Crewe Advisors first reported a position in TMO in Q4 2017 and has held it in 29 quarters since. The position peaked at $939K in Q1 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Crewe Advisors held 926 shares of Thermo Fisher Scientific worth $464K as of Q2 2026.
  • Crewe Advisors bought 68 Thermo Fisher Scientific shares in Q2 2026, an estimated $32.6K.
  • Thermo Fisher Scientific made up 0.03% of Crewe Advisors's portfolio in Q2 2026, its #151 holding.
  • Crewe Advisors first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 29 quarters since.
  • Crewe Advisors's Thermo Fisher Scientific position peaked at $939K in Q1 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.